Reaction

Pulmonary Arterial Pressure Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,614 reports · 30 co-occurring drugs

As of the last recalculation, Pulmonary Arterial Pressure Increased appears in 1,614 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is SELEXIPAG (PRR 109.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Selexipag194109.9110.8
Epoprostenol102107.2108.0
Riociguat17879.079.4
Macitentan33177.377.7
Sildenafil Powder,17269.670.0
Sildenafil25567.267.5
Treprostinil46767.167.4
Bosentan19255.655.8
Sildenafil Citrate38851.451.6
Tadalafil29345.946.0
0Xygen13739.139.2
Oxygen13739.139.2
Eplerenone3738.138.2
Ambrisentan29036.336.4
Metolazone2225.625.6
Digoxin8415.915.9
Spironolactone13413.313.3
Torsemide3313.113.1
Bumetanide2411.911.9
Sevoflurane710.910.9
Warfarin9810.510.5
Bosutinib710.110.1
Norepinephrine Bitartrate119.99.9
Cetirizine Hcl79.99.9
Norepinephrine89.79.7
Amphetamine46.26.2
Tolvaptan76.26.2
Brimonidine Tartrate85.85.8
Nintedanib145.85.8
Sevelamer Carbonate55.65.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.